EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biohit Oyj's enterprise value is €23.81 Mil.
Biohit Oyj's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €13.08 Mil. Therefore, Biohit Oyj's EV-to-Revenue for today is 1.82.
The historical rank and industry rank for Biohit Oyj's EV-to-Revenue or its related term are showing as below:
OHEL:BIOBV'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.19 Med: 4.8 Max: 36.03
Current: 1.82
During the past 13 years, the highest EV-to-Revenue of Biohit Oyj was 36.03. The lowest was 1.19. And the median was 4.80.
OHEL:BIOBV's EV-to-Revenue is ranked better than 81.47% of 1036
companies
in the Biotechnology industry
Industry Median: 7.96
vs OHEL:BIOBV: 1.82
As of today (2024-05-14), Biohit Oyj's stock price is €1.98.
Biohit Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.86. Therefore, Biohit Oyj's PS Ratio for today is 2.29.
Biohit Oyj EV-to-Revenue Historical Data
The historical data trend for Biohit Oyj's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biohit Oyj's EV-to-Revenue
For the Biotechnology subindustry, Biohit Oyj's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biohit Oyj's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biohit Oyj's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Biohit Oyj's EV-to-Revenue falls into.
Biohit Oyj's current Enterprise Value is €23.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biohit Oyj's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €13.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biohit Oyj's share price for today is €1.98.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biohit Oyj EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Biohit Oyj's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OHEL:BIOBV has been successfully added to your 